FDA's Plan B OTC Switch Decision Deadline Is Sept. 1, HHS' Leavitt Says

Sens. Clinton and Murray lift their hold on FDA Acting Commissioner Crawford's nomination after a letter from HHS secretary says FDA action on Barr's Rx-to-OTC switch application is imminent.